Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Shares Outstanding (Diluted) (2010 - 2026)

Updated

Vistagen Therapeutics' Weighted Average Shares Outstanding (Diluted) was 44.44 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 24.3% from 35.75 million a year earlier and up 3.4% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Weighted Average Shares Outstanding (Diluted) at Vistagen Therapeutics came in at 38.07 million, up 23.3% from FY2025.

  • Weighted Average Shares Outstanding (Diluted) has now increased for three consecutive fiscal years, with a five-year compound annual growth rate of 264.8% (FY2021 to FY2026).
  • In earlier fiscal years, Weighted Average Shares Outstanding (Diluted) was 30.88 million in FY2025 (+59.5%), 19.35 million in FY2024 (+178.1%), 6.96 million in FY2023 and 58,926 in FY2022 (unchanged).
  • The fiscal Q2 2027 figure marks the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to fiscal Q4 2011.
  • Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) has increased for 14 straight quarters, with growth averaging 25.6% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Weighted Average Shares Outstanding (Diluted) ranged from 0.0% (fiscal Q3 2022) to 326.2% (fiscal Q3 2024).
  • Per Business Quant data, VTGN's Weighted Average Shares Outstanding (Diluted) in the three fiscal quarters before Q2 2027 was 42.98 million (Q1 2027), 38.07 million (Q4 2026) and 42.23 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 9,988.36 Bn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 893.40 Mn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 2.45 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 1.77 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 2.48 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - 1.96 Bn
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 1.25 Bn
9 Gsk 193.54 Bn 176.38 Bn - 4.11 Bn
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 44.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 44.44 Mn
Jun 30, 2026 42.98 Mn
Mar 31, 2026 38.07 Mn
Dec 31, 2025 42.23 Mn
Sep 30, 2025 35.75 Mn
Jun 30, 2025 31.93 Mn
Mar 31, 2025 30.88 Mn
Dec 31, 2024 30.71 Mn
Sep 30, 2024 30.63 Mn
Jun 30, 2024 30.60 Mn
Mar 31, 2024 19.35 Mn
Dec 31, 2023 29.39 Mn
Sep 30, 2023 10.04 Mn
Jun 30, 2023 7.34 Mn
Mar 31, 2023 6.96 Mn
Dec 31, 2022 6.89 Mn
Sep 30, 2022 6.89 Mn
Jun 30, 2022 6.89 Mn
Mar 31, 2022 1.77 Mn
Dec 31, 2021 1.77 Mn
API Access

Vistagen Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=VTGN&period=max&api_key=YOUR_API_KEY